Phase II study of weekly paclitaxel for docetaxel-resistant metastatic breast cancer in Japan. [electronic resource]
Producer: 20050214Description: 509-13 p. digitalISSN:- 1075-122X
- Adult
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Docetaxel
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Female
- Humans
- Japan
- Middle Aged
- Neoplasm Metastasis
- Paclitaxel -- administration & dosage
- Palliative Care
- Survival Analysis
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.